Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Sagimet Biosciences Inc (NASDAQ: SGMT) closed at $9.58 in the last session, up 0.31% from day before closing price of $9.55. In other words, the price has increased by $0.31 from its previous closing price. On the day, 0.66 million shares were traded. SGMT stock price reached its highest trading level at $10.0624 during the session, while it also had its lowest trading level at $9.45.
Ratios:
We take a closer look at SGMT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 20.26 and its Current Ratio is at 20.26. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on August 11, 2025, initiated with a Outperform rating and assigned the stock a target price of $28.
On July 24, 2025, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $28.Canaccord Genuity initiated its Buy rating on July 24, 2025, with a $28 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 21 ’25 when Happel David sold 65,478 shares for $9.13 per share. The transaction valued at 598,115 led to the insider holds 689,722 shares of the business.
Martins Eduardo Bruno sold 8,277 shares of SGMT for $75,607 on Jul 21 ’25. The Chief Medical Officer now owns 106,936 shares after completing the transaction at $9.13 per share. On Jul 21 ’25, another insider, Rozek Elizabeth, who serves as the General Counsel and CCO of the company, sold 10,780 shares for $9.13 each. As a result, the insider received 98,471 and left with 183,726 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMT now has a Market Capitalization of 308430976 and an Enterprise Value of 186301920.
Stock Price History:
The Beta on a monthly basis for SGMT is 3.41, which has changed by 2.4710145 over the last 52 weeks, in comparison to a change of 0.16657472 over the same period for the S&P500. Over the past 52 weeks, SGMT has reached a high of $11.41, while it has fallen to a 52-week low of $1.73. The 50-Day Moving Average of the stock is 14.48%, while the 200-Day Moving Average is calculated to be 83.71%.
Shares Statistics:
According to the various share statistics, SGMT traded on average about 1.57M shares per day over the past 3-months and 593740 shares per day over the past 10 days. A total of 32.20M shares are outstanding, with a floating share count of 25.75M. Insiders hold about 20.00% of the company’s shares, while institutions hold 35.10% stake in the company. Shares short for SGMT as of 1753920000 were 3211457 with a Short Ratio of 2.05, compared to 1751241600 on 3629995. Therefore, it implies a Short% of Shares Outstanding of 3211457 and a Short% of Float of 11.310001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The firm’s stock currently is rated by 3.0 analysts. The consensus estimate for the next quarter is -$0.4, with high estimates of -$0.36 and low estimates of -$0.43.
Analysts are recommending an EPS of between -$1.64 and -$1.69 for the fiscal current year, implying an average EPS of -$1.66. EPS for the following year is -$2.37, with 9.0 analysts recommending between -$1.27 and -$3.46.
